Shares of Meihua International Medical Technologies Co. Ltd. (MHUA) gained 8% on Wednesday morning after its NT-2000 surgical path analysis system facilitates world's second 5G remote robot-assisted lobectomy.
MHUA is currently trading at $1.1200, up $0.0900 or 8.7260%, on the Nasdaq. The stock opened its trading at $1.2599 after closing Tuesday at $1.0300. The stock has traded between $0.6010 and $3.9900 in the past 52-week period.
Meihua International announced that its NT-2000 surgical path analysis system successfully supported the world's second 5G remote robot-assisted lobectomy.
This procedure was performed on July 15, 2024, at Yangzhou University Affiliated Hospital by a team from Shanghai Chest Hospital.
"We are honored that our cutting-edge technology could assist the advanced 3D imaging for surgical mapping in this sophisticated procedure," said Mr. Yongjun Liu, Chairman of Meihua, "Despite a physical distance of over 200 kilometers between the surgical team and the patient, the operation was executed seamlessly in just one hour, thanks to 5G technology and the precision of the robotic surgical system."
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.